Although osteoporosis is most prevalent among postmenopausal women, both genders and all age groups are at risk. Nevertheless, the condition is still overlooked and undertreated. Despite a plethora of prevention and screening recommendations, not many patients receive early diagnosis and effective care.
During this satellite symposium, a multidisciplinary panel will discuss the impact osteoporosis has on patients and the innovative strategies—pharmacologic and nonpharmacologic—that can improve outcomes. They will also present patient cases, review recent treatment guidelines, and examine the latest information on anti-catabolic and anabolic agents.
The learning objectives of this program are:
This educational program is directed toward OB/GYNs. PCPs, NPs, and PAs who treat women with osteoporosis are also invited to participate.
What You'll Experience
Benefits of Attending
Date and Time:
This webinar will be held on:
John P. Bilezikian, MD
Chief, Division of Endocrinology
Director of the Metabolic Bone Diseases Program
Columbia University Medical Center
Dorothy L. and Daniel H. Silberberg Professor of Medicine and Professor of Pharmacology
College of Physicians & Surgeons, Columbia University
New York, NY
Join PER® for this virtual, interactive event!
Explore the latest insights and advancements within this high-impact oncology CME meeting alongside our renowned faculty experts.